Financial implications of male circumcision scale-up for the prevention of HIV and other sexually transmitted infections in a sub-saharan african community

Sexually Transmitted Diseases

Volumn 40, Issue 7, 2013, Pages 559-568

  Kacker, Seema ^a   Frick, Kevin D ^b   Quinn, Thomas C ^a,c   Gray, Ronald H ^b   Tobian, Aaron A R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICA; ARTICLE; CIRCUMCISION; COST CONTROL; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; MALE; OUTCOME ASSESSMENT; SCALE UP; SEXUALLY TRANSMITTED DISEASE; COHORT ANALYSIS; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; GENITAL DISEASES, MALE; HERPES GENITALIS; MIDDLE AGED; MONTE CARLO METHOD; PAPILLOMAVIRUS INFECTIONS; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS INFECTIONS; UGANDA; VAGINOSIS, BACTERIAL; YOUNG ADULT;

ADOLESCENT; ADULT; CIRCUMCISION, MALE; COHORT STUDIES; COST-BENEFIT ANALYSIS; FEMALE; GENITAL DISEASES, MALE; HERPES GENITALIS; HUMANS; MALE; MIDDLE AGED; MONTE CARLO METHOD; PAPILLOMAVIRUS INFECTIONS; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS INFECTIONS; UGANDA; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 84888582809     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3182945e56     Document Type: Article

References (39)

1. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Med 2005; 2:e298.
2. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet 2007; 369:643-656.
3. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. Lancet 2007; 369:657-666.
4. UNAIDS. Joint Strategic Action Framework to Accelerate the Scale- Up of Voluntary Medical Male Circumcision for HIV Prevention in Eastern and Southern Africa: 2012-2016. Geneva: UNAIDS: Joint United Nations Programme on HIV/AIDS, 2011.
5. Ministry of Public Health and Sanitation. Progress report on Kenya's Voluntary Medical Male Circumcision Programme, 2008-2010. NASC, ed. Nairobi, Kenya: Government of Kenya, 2012.
6. Tobian AA, Gray RH. The medical benefits of male circumcision. JAMA 2011; 306:1479-1480.
7. Wawer MJ, Tobian AA, Kigozi G, et al. Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: A randomised trial in Rakai, Uganda. Lancet 2011; 277:209-218.
8. Gray RH, Kigozi G, Serwadda D, et al. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2009; 200:42 e41-e47.
9. Hankins C, Forsythe S, Njeuhmeli E. Voluntary medical male circumcision: An introduction to the cost, impact, and challenges of accelerated scaling up. PLoS Med 2011; 8:e1001127.
10. UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention. Male circumcision for HIV prevention in high HIV prevalence settings: What can mathematical modelling contribute to informed decision making? PLoS Med 2009; 6:e1000109.
11. Ministry of Health (MOH) Uganda and ORC Macro. Uganda HIV/AIDS Sero-behavioral Survey 2004-2005. Calverton, MA, USA: Ministry of Health and ORC Macro, 2006.
12. Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. New Engl J Med 2009; 360:1298-1309.
13. Suntoke TR, Hardick A, Tobian AA, et al. Evaluation of multiplex real-time PCR for detection of H. ducreyi, T. pallidum, HSV-1, and HSV-2 in the diagnosis of genital ulcer disease in Rakai District, Uganda. Sex Transm Infect 2009; 85:97-101.
14. The World Bank. World DataBank: World Development Indicators & Global Development Finance, 2010.
15. Uganda Bureau of Statistics. Projections of Demographic Trends in Uganda: 2007-2017, 2007.
16. World Health Organization. Mortality andBurden ofDisease: Life Tables. Uganda: 2009. 2011. Available at: http://apps.who.int/ghodata/?vid=720.
17. Hladik W, Musinguzi J, Kirungi W, et al. The estimated burden of HIV/AIDS in Uganda, 2005-2010. AIDS 2008; 22:503-510.
18. United States Department of Labor. Bureau of Labor Statistics. Consumer Price IndexVAll Urban Consumers. 2013. Available at: http://data.bls.gov/cgi- bin/surveymost. Accessed January 22, 2013.
19. UNAIDS. Scaling-up male circumcision programmes in the Eastern and SouthernAfrica Region: Country updatemeeting to share lessons, explore opportunities and overcome challenges to scale-up. Paper presented at: Joint United Nations Programme on HIV/AIDS; 2010; Arusha, Tanzania.
20. Tobian AA, Gray RH, Quinn TC. Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: The case for neonatal circumcision. Arch Pediatr Adolesc Med 2010; 164:78-84.
21. Auvert B, Sobngwi-Tambekou J, Cutler E, et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: Results of a randomized controlled trial conducted in orange farm, South Africa. J Infect Dis 2009; 199:14-19.
22. Uganda Bureau of Statistics (UBOS) and Macro International Inc. Uganda Demographic and Health Survey 2006. Calverton, MD, USA: UBOS and Macro International Inc, 2007.
23. Thoma ME, Gray RH, Kiwanuka N, et al. The short-term variability of bacterial vaginosis diagnosed by Nugent Gram stain criteria among sexually active women in Rakai, Uganda. Sex Transm Dis 2011; 38:111-116.
24. Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003; (31):14-19.
25. Hu D, Goldie S. The economic burden of noncervical human papillomavirus disease in the United States. Am J Obstet Gynecol 2008; 198:500 e501-e507.
26. Goldie SJ, O'Shea M, Campos NG, et al. Health and economic outcomes of HPV 16, 18 vaccination in 72 GAVI-eligible countries. Vaccine 2008; 26:4080-4093.
27. Goldhaber-Fiebert JD, Stout NK, Salomon JA, et al. Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccination. J Natl Cancer Inst 2008; 100:308-320.
28. World Health Organization. CHOosing Interventions that are Cost Effective (WHO-CHOICE). 2012. Available at: http://www.who.int/choice/country/country- specific/en/index.html.
29. Frye JE. International Drug Price Indicator Guide. Management Sciences for Health, 2011.
30. Sexually Transmitted Infections Treatment Guidelines for Use by Operational Level Health Workers in Uganda. STD Control Unit. STD/AIDS Control Programme. Ministry of Health U, 2003.
31. UNAIDS. World Health Organization Technical Consultation on Male Circumcision and HIV Prevention: Policy and Programme Implications. Conclusions and Recommendations. World Health Organization/Joint United Nations Programme on HIV/AIDS: Geneva: World Health Organization, 2007.
32. USAID. The Potential Cost and Impact of Expanding Male Circumcision inUganda. 2009.Available at: http://www.malecircumcision.org/programs/documents/ Uganda102909.pdf. Accessed August 1, 2012.
33. Gray R, Kigozi G, Kong X, et al. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study. AIDS 2012; 26:609-615.
34. Schoen EJ, Colby CJ, Ray GT. Newborn circumcision decreases incidence and costs of urinary tract infections during the first year of life. Pediatrics 2000; 105(4 pt 1):789-793.
35. Weiss HA, Thomas SL, Munabi SK, et al.Male circumcision and risk of syphilis, chancroid, and genital herpes: A systematic review and meta-analysis. Sex Transm Infect 2006; 82:101-109; discussion 110.
36. Mehta SD, Gaydos C, Maclean I, et al. The effect of medical male circumcision on urogenital Mycoplasma genitalium among men in Kisumu, Kenya. Sex Transm Dis 2012; 39:276-280.
37. Wawer MJ, Makumbi F, Kigozi G, et al. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: A randomised controlled trial. Lancet 2009; 374:229-237.
38. Weiss HA, Hankins CA, Dickson K. Male circumcision and risk of HIV infection in women: A systematic review and meta-analysis. Lancet Infect Dis 2009; 9:669-677.
39. Mehta SD, Moses S, Parker CB, et al. Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection. AIDS 2012; 26(9):1141-1149.